Cargando…
Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas
BRCA1 and BRCA2 mutations are responsible for hereditary breast and ovarian cancer, but they also confer an increased risk for the development of rarer cancers associated with this syndrome, namely, cancer of the pancreas, male breast, peritoneum, and fallopian tube. The objective of this work was t...
Autores principales: | Pinto, Pedro, Peixoto, Ana, Santos, Catarina, Rocha, Patrícia, Pinto, Carla, Pinheiro, Manuela, Leça, Luís, Martins, Ana Teresa, Ferreira, Verónica, Bartosch, Carla, Teixeira, Manuel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988637/ https://www.ncbi.nlm.nih.gov/pubmed/27532258 http://dx.doi.org/10.1371/journal.pone.0161438 |
Ejemplares similares
-
Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects
por: Peixoto, Ana, et al.
Publicado: (2020) -
Gene Panel Tumor Testing in Ovarian Cancer Patients Significantly Increases the Yield of Clinically Actionable Germline Variants beyond BRCA1/BRCA2
por: Barbosa, Ana, et al.
Publicado: (2020) -
Combined germline and tumor mutation signature testing identifies new families with NTHL1 tumor syndrome
por: Pinto, Carla, et al.
Publicado: (2023) -
Malignant neoplasms associated with cancer of the ampulla of Vater.
por: Hatch, E. E., et al.
Publicado: (1992) -
Undifferentiated carcinoma of the ampulla of Vater
por: Yamada, Misuzu, et al.
Publicado: (2017)